Drugs Made In America Acquisition Corp. Units (DMAAU) Stock Ticker
Market factors today
Unlock the full DMAAU picture
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.
DMAAU stock facts
| Ticker symbol | DMAAU |
| Exchange | NASDAQ Global Market |
| Sector | Financial Services |
| Industry | Shell Companies |
| Market cap | $354.5M |
| CEO | Roger Bendelac |
| Employees | 2 |
| Headquarters | New York, NY, US |
| IPO date | 2025-01-27 |
| Website | dmaacorp.com |
What you can see for DMAAU on Tickr
Live DMAAU price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DMAAU report.
Rankings
FAQ
What is the ticker symbol for Drugs Made In America Acquisition Corp. Units?
The ticker symbol for Drugs Made In America Acquisition Corp. Units is DMAAU, listed on the NASDAQ Global Market.
What is DMAAU?
Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.